Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with chronic lung disease and pulmonary hypertension
Abstract Background Pulmonary hypertension (PH) confers increased mortality in patients with chronic lung disease, yet there remains a lack of validated risk assessment tools to prognosticate these patients. We aimed to create a risk assessment tool to stratify patients with chronic lung disease and...
Saved in:
Main Authors: | Shameek Gayen, Jay Pescatore, Matthew Bittner, Mario Naranjo, Gerard J. Criner, Sheila Weaver, Temple Lung Center Pulmonary Vascular Disease Working Group |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12890-025-03538-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: short- and long-term results from a cohort in Brazil
by: Fabio Solano de Freitas Souza, et al.
Published: (2025-01-01) -
Dicrotic notch index in pulmonary hypertension: correlation with hemodynamic, echocardiographic and clinical parameters
by: Mustafa Oguz, et al.
Published: (2024-11-01) -
The possibilities of lung perfusion scintigraphy in the diagnosis of pulmonary embolism and chronic thromboembolic pulmonary hypertension
by: V.Yu. Kundin, et al.
Published: (2017-06-01) -
A novel dual fixation method for improving the reliable assessment of pulmonary vascular morphology in pulmonary hypertension rats
by: Yan Xu, et al.
Published: (2025-01-01) -
The contemporary echocardiography approach to diagnosis of pulmonary hypertension and non-invasive estimation of pulmonary artery pressure
by: M.Yu. Kolesnyk
Published: (2018-06-01)